SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-217581
Filing Date
2021-07-16
Accepted
2021-07-16 17:21:39
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d180826ds3.htm S-3 323949
2 EX-4.4 d180826dex44.htm EX-4.4 288655
3 EX-5.1 d180826dex51.htm EX-5.1 41830
4 EX-23.1 d180826dex231.htm EX-23.1 1749
5 EX-23.2 d180826dex232.htm EX-23.2 1497
6 GRAPHIC g180826dsp1.jpg GRAPHIC 2042
7 GRAPHIC g180826g10m87.jpg GRAPHIC 61229
  Complete submission text file 0001193125-21-217581.txt   746340
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-257990 | Film No.: 211096260
SIC: 2834 Pharmaceutical Preparations